IRIS
MISSALE, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.905
AS - Asia 5.502
EU - Europa 3.770
SA - Sud America 1.013
AF - Africa 324
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.739
SG - Singapore 2.443
CN - Cina 1.552
BR - Brasile 831
IE - Irlanda 826
IT - Italia 722
SE - Svezia 666
HK - Hong Kong 494
DE - Germania 383
VN - Vietnam 324
NL - Olanda 221
ZA - Sudafrica 219
FR - Francia 217
FI - Finlandia 207
TR - Turchia 182
IN - India 107
RU - Federazione Russa 107
GB - Regno Unito 97
CA - Canada 95
AR - Argentina 81
UA - Ucraina 75
AT - Austria 62
KR - Corea 60
BD - Bangladesh 54
JP - Giappone 47
MX - Messico 46
IQ - Iraq 42
CI - Costa d'Avorio 39
ID - Indonesia 33
PL - Polonia 32
BE - Belgio 31
PK - Pakistan 24
CO - Colombia 23
CZ - Repubblica Ceca 21
ES - Italia 21
EC - Ecuador 18
UZ - Uzbekistan 18
VE - Venezuela 18
LT - Lituania 15
MA - Marocco 15
KE - Kenya 14
CL - Cile 13
AE - Emirati Arabi Uniti 12
PY - Paraguay 12
AZ - Azerbaigian 11
MY - Malesia 10
RO - Romania 10
EG - Egitto 9
IR - Iran 9
KZ - Kazakistan 9
DK - Danimarca 8
KH - Cambogia 7
PE - Perù 7
AU - Australia 6
CH - Svizzera 6
DZ - Algeria 6
IL - Israele 6
PA - Panama 6
TH - Thailandia 6
TW - Taiwan 6
UY - Uruguay 6
AM - Armenia 5
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EU - Europa 5
LU - Lussemburgo 5
OM - Oman 5
TN - Tunisia 5
BY - Bielorussia 4
KG - Kirghizistan 4
LV - Lettonia 4
PS - Palestinian Territory 4
RS - Serbia 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
EE - Estonia 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
QA - Qatar 3
AO - Angola 2
BN - Brunei Darussalam 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
LY - Libia 2
NP - Nepal 2
SA - Arabia Saudita 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
UG - Uganda 2
Totale 16.507
Salva come PNG Salva come JPEG
Città #
Singapore 1.245
Dublin 826
Ashburn 818
Chandler 620
Dallas 556
Santa Clara 544
Hong Kong 486
Beijing 388
Boardman 251
Parma 224
Johannesburg 204
Ann Arbor 201
Dearborn 191
Shanghai 171
New York 153
Princeton 147
Los Angeles 142
Izmir 131
Nanjing 119
Munich 116
Ho Chi Minh City 106
Wilmington 99
São Paulo 92
Hefei 88
Hanoi 83
Grafing 77
Helsinki 72
Jacksonville 69
Milan 69
Columbus 63
Moscow 59
Jinan 55
Seoul 54
Shenyang 51
Vienna 48
Des Moines 47
Tokyo 45
Bremen 43
Seattle 41
Abidjan 39
Buffalo 38
Chicago 38
Tianjin 37
Turku 36
Toronto 35
The Dalles 33
Bengaluru 32
Hebei 32
Rio de Janeiro 32
Rome 32
Kunming 31
Guangzhou 30
Kocaeli 30
Nuremberg 30
Bologna 29
Frankfurt am Main 29
Montreal 28
Nanchang 28
Council Bluffs 27
Warsaw 27
Changsha 24
Brooklyn 23
Brussels 23
Jakarta 23
Redmond 23
Ardea 22
Stockholm 22
Phoenix 21
Zhengzhou 21
Belo Horizonte 20
Jiaxing 20
London 20
Denver 19
Orem 19
Atlanta 18
Houston 18
Norwalk 18
San Mateo 18
Boston 17
Chennai 17
Reggio Emilia 17
Düsseldorf 16
San Jose 16
Dhaka 15
Fairfield 15
Fremont 15
Hangzhou 15
Mexico City 15
Salvador 15
Woodbridge 15
Tashkent 14
Falls Church 13
Haiphong 13
Amsterdam 12
Baghdad 12
Istanbul 12
Manchester 12
Nairobi 12
San Francisco 12
Baku 11
Totale 10.150
Salva come PNG Salva come JPEG
Nome #
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J. 256
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 255
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 239
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 228
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 201
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 193
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 181
A simplified sars-cov-2 pseudovirus neutralization assay 178
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 157
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 148
Metabolic regulation of the HBV-specific T cell function 147
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 143
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 137
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 136
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma 134
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 134
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells (Frontiers in Oncology, (2022), 12, (942341), 10.3389/fonc.2022.942341) 134
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 132
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature 131
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 131
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 131
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 130
Correlation between LDH levels and response to sorafenib in HCC patients: An analysis of the ITA.LI.CA database 130
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 129
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 128
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 128
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy 128
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 125
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 125
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 125
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 124
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 123
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 123
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 123
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 121
HBV immune-therapy: From molecular mechanisms to clinical applications 120
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab 120
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 120
T cell regulation in HBV-related chronic liver disease 120
L-Asparaginase and Inhibitors of Glutamine Synthetase DiscloseGlutamine Addiction of Beta-Catenin-Mutated Human HepatocellularCarcinoma Cells 118
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 118
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 117
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 117
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 115
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 113
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 111
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 110
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 108
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 105
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 105
The changing scenario of hepatocellular carcinoma in Italy: an update 105
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 104
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 104
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 102
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 102
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 102
Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychologial follow-up 101
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 101
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 100
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes 99
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use 99
Fine specificity of the human T cell response to hepatitis B virus core antigen 98
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 98
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 97
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 96
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer. 96
COMPOSTO E COMPOSIZIONE PER IL RIPRISTINO METABOLICO E FUNZIONALE DEI LINFOCITI NK NELL’EPATOCARCINOMA E RELATIVO METODO 95
AISF position paper on HCV in immunocompromised patients 95
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 95
[Surgical risks for cirrhotic patients] 95
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics 94
Etanercept in the treatment of psoriasis and psoriathic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients 94
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 94
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 92
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 92
Immune pathogenesis of hepatitis B 92
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 92
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 91
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 90
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 90
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro 90
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 89
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 89
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 89
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial 88
In reply 88
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 88
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 87
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 87
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 85
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor 85
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection 84
Metabolic disorders across hepatocellular carcinoma in Italy 84
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 84
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 84
Comparative pathogenesis of HBV and HCV 83
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 82
Combination of radiofrequency ablation and immunotherapy 82
Hepatitis B Virus Maintains Its Pro-oncogenic Properties in the Case of Occult HBV Infection 82
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 82
Totale 11.622
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021500 0 0 0 0 0 53 72 72 144 70 54 35
2021/2022727 19 21 26 53 47 91 38 54 36 21 44 277
2022/20232.802 318 250 185 172 168 298 53 157 988 25 116 72
2023/20241.260 72 122 42 57 113 292 85 88 46 74 92 177
2024/20254.417 91 221 279 233 492 548 224 198 576 421 361 773
2025/20265.265 830 877 1.142 850 1.268 298 0 0 0 0 0 0
Totale 16.829